PRDM9 and breast cancer: Some of the first evidence that BPA-induced epigenetic changes affect breast cancer pathogenesis was provided by the finding that treatment of MCF-7 cells with BPA increases mRNA and protein expression of EZH2, a histone methyltransferase linked to breast cancer risk.